Interaction between vasopressin and angiotensin II in vivo and in vitro: Effect on aquaporins and urine concentration

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 3, 2010, Pages

  Wang, Weidong ^a   Li, Chunling ^a   Summer, Sandra ^a   Falk, Sandor ^a   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Aquaporin; cAMP; Urine concentration

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANTIDIURETIC AGENT; AQUAPORIN; ARGIPRESSIN[1 DEAMINO]; LOSARTAN; SLC12A1 PROTEIN, RAT; SODIUM INTAKE; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 2; VASOPRESSIN DERIVATIVE;

ANIMAL; ANIMAL MODEL; DRUG EFFECTS; KIDNEY COLLECTING TUBULE; KIDNEY CONCENTRATING CAPACITY; MALE; METABOLISM; OSMOLARITY; PHARMACOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SODIUM INTAKE; WISTAR RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIDIURETIC AGENTS; AQUAPORINS; DEAMINO ARGININE VASOPRESSIN; KIDNEY CONCENTRATING ABILITY; KIDNEY TUBULES, COLLECTING; LOSARTAN; MALE; MODELS, ANIMAL; OSMOLAR CONCENTRATION; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; SODIUM, DIETARY; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; SODIUM-POTASSIUM-EXCHANGING ATPASE; SOLUTE CARRIER FAMILY 12, MEMBER 1; VASOPRESSINS;

EID: 77956482828     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00168.2010     Document Type: Article

References (30)

1. Bens M, Vallet V, Cluzeaud F, Pascual-Letallec L, Kahn A, Rafestin-Oblin ME, Rossier BC, Vandewalle A. Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line. J Am Soc Nephrol 10: 923-934, 1999.
2. Bouby N, Hus-Citharel A, Marchetti J, Bankir L, Corvol P, Llorens-Cortes C. Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron. J Am Soc Nephrol 8: 1658-1667, 1997. (Pubitemid 27475866)
3. 2-receptor agonist/antagonist treatment. Am J Physiol Renal Physiol 278: F29-F42, 2000.
4. Ecelbarger CA, Terris J, Frindt G, Echevarria M, Marples D, Nielsen S, Knepper MA. Aquaporin-3 water channel localization and regulation in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 269: F663-F672, 1995. (Pubitemid 3006016)
5. - cotransporter, BSC-1. Am J Physiol Renal Fluid Electrolyte Physiol 271: F619-F628, 1996.
6. Fernandez-Llama P, Andrews P, Turner R, Saggi S, Dimari J, Kwon TH, Nielsen S, Safirstein R, Knepper MA. Decreased abundance of collecting duct aquaporins in post-ischemic renal failure in rats. J Am Soc Nephrol 10: 1658-1668, 1999.
7. Frøkiær J, Marples D, Valtin H, Morris JF, Knepper MA, Nielsen S. Low aquaporin-2 levels in polyuric DI +/+ severe mice with constitutively high cAMP-phosphodiesterase activity. Am J Physiol Renal Physiol 276: F179-F190, 1999.
8. Fushimi K, Sasaki S, Marumo F. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J Biol Chem 272: 14800-14804, 1997.
9. Gong H, Wang W, Kwon TH, Jonassen T, Li C, Ring T, Frokiaer J, Nielsen S. EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 66: 683-695, 2004.
10. Grinevich V, Knepper MA, Verbalis J, Reyes I, Aguilera G. Acute endotoxemia in rats induces down-regulation of V2 vasopressin receptors and aquaporin-2 content in the kidney medulla. Kidney Int 65: 54-62, 2004. (Pubitemid 38037491)
11. Hasler U, Mordasini D, Bens M, Bianchi M, Cluzeaud F, Rousselot M, Vandewalle A, Feraille E, Martin PY. Long term regulation of aquaporin-2 expression in vasopressin-responsive renal collecting duct principal cells. J Biol Chem 277: 10379-10386, 2002. (Pubitemid 34968157)
12. Homma S, Gapstur SM, Coffey A, Valtin H, Dousa TP. Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus. Am J Physiol Renal Fluid Electrolyte Physiol 261: F345-F353, 1991.
13. Klingler C, Ancellin N, Barrault MB, Morel A, Buhler JM, Elalouf JM, Clauser E, Lugnier C, Corman B. Angiotensin II potentiates vasopressin-dependent cAMP accumulation in CHO transfected cells. Mechanisms of cross-talk between AT1A and V2 receptors. Cell Signal 10: 65-74, 1998.
14. Knepper MA, Kim GH, Fernandez-Llama P, Ecelbarger CA. Regulation of thick ascending limb transport by vasopressin. J Am Soc Nephrol 10: 628-634, 1999.
15. Kwon TH, Frøkiær J, Fernandez-Llama P, Knepper MA, Nielsen S. Reduced abundance of aquaporins in rats with bilateral ischemia-induced acute renal failure: prevention by α-MSH. Am J Physiol Renal Physiol 277: F413-F427, 1999.
16. Kwon TH, Nielsen J, Knepper MA, Frøkiær J, Nielsen S. Angiotensin II AT1 receptor blockade decreases vasopressin-induced water reabsorption and AQP2 levels in NaCl-restricted rats. Am J Physiol Renal Physiol 288: F673-F684, 2005. (Pubitemid 40381734)
17. Lee YJ, Song IK, Jang KJ, Nielsen J, Frøkiær J, Nielsen S, Kwon TH. Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. Am J Physiol Renal Physiol 292: F340-F350, 2007.
18. Matsumura Y, Uchida S, Rai T, Sasaki S, Marumo F. Transcriptional regulation of aquaporin-2 water channel gene by cAMP. J Am Soc Nephrol 8: 861-867, 1997.
19. Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, Knepper MA. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci USA 92: 1013-1017, 1995.
20. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82: 205-244, 2002.
21. Paxton WG, Runge M, Horaist C, Cohen C, Alexander RW, Bernstein KE. Immunohistochemical localization of rat angiotensin II AT1 receptor. Am J Physiol Renal Fluid Electrolyte Physiol 264: F989-F995, 1993.
22. Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol 17: 1820-1832, 2006.
23. Schrier RW. Interactions between angiotensin II and arginine vasopressin in water homeostasis. Kidney Int 76: 137-139, 2009.
24. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 341: 577-585, 1999.
25. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355: 2099-2112, 2006.
26. Torikai S, Imai M. Effects of solute concentration on vasopressin stimulated cyclic AMP generation in the rat medullary thick ascending limbs of Henle's loop. Pflügers Arch 400: 306-308, 1984. (Pubitemid 14110279)
27. Torp M, Brond L, Hadrup N, Nielsen JB, Praetorius J, Nielsen S, Christensen S, Jonassen TE. Losartan decreases vasopressin-mediated cAMP accumulation in the thick ascending limb of the loop of Henle in rats with congestive heart failure. Acta Physiol (Oxf) 190: 339-350, 2007.
28. Turban S, Beutler KT, Morris RG, Masilamani S, Fenton RA, Knepper MA, Packer RK. Long-term regulation of proximal tubule acid-base transporter abundance by angiotensin II. Kidney Int 70: 660-668, 2006.
29. Wang W, Li C, Summer SN, Falk S, Cadnapaphornchai MA, Chen YC, Schrier RW. Molecular analysis of impaired urinary diluting capacity in glucocorticoid deficiency. Am J Physiol Renal Physiol 290: F1135-F1142, 2006.
30. Wong NL, Tsui JK. Angiotensin II upregulates the expression of vasopressin V2 mRNA in the inner medullary collecting duct of the rat. Metabolism 52: 290-295, 2003.